Skip to main content
OpenTrials
Completed

NCT Number: NCT03941899

The Analgesic Effect of QLB II After Robotic Prostatectomy. (QLB II: Quadratus Lomborum Block II Type)

The analgesic effects of Quadratus Lomborum Block II type after robotic-assisted laparoscopic radical prostatectomy, will be assessed.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Postoperative Pain Neurologic Manifestations Pain Pain, Postoperative Pathologic Processes Pathological Conditions, Signs and Symptoms Postoperative Complications Signs and Symptoms

Age range

18 year–85 year

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

San Salvatore Academic Hospital

Coppito, L'Aquila, 67100, Italy

About this study

Quadratus Lomborum Block II type will be performed before performing robotic-assisted laparoscopic radical prostatectomy.

The post-operative analgesic effect will be assessed, by using Numeric Rate Scale for pain.

The pain assessment will be evaluated during the first 24 hours from surgery. The opioids requirement and side effects will be also assessed.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • American Society of Anesthesiologist status I-III
  • Written informed consent

Exclusion criteria

  • Body mass Index > 35 kg/m2
  • Allergies to local anesthetics
  • primaries or secondaries coagulopathies
  • addiction to drugs
  • severe kidney and liver diseases
  • cognitive impairment

Treatment and study plan

Levobupivacaine in QLB II

Other

Quadratus Lomborum Block II type will be performed by injecting levobupivacaine 0.375% 20 ml between latissimus dorsi and quadratus lomborum muscle.

Other names: Quadratus Lomborum Block II type

Primary outcomes

  1. Analgesia

    Time frame: The first 24 hours from surgery

    Pain assessment by using Numeric Rate Scale for pain

Secondary outcomes

  1. Opioids

    Time frame: The first 24 hours from surgery

    The opioids requirement (mg of equianalgesic morphine) will be assessed

  2. Postoperative Nausea and Vomiting

    Time frame: The first 24 hours from surgery

    The postoperative nausea and vomiting will be assessed

  3. Bowel function

    Time frame: The first 24 hours from surgery

    The recovery of bowel function will be assessed

  4. Length of stay

    Time frame: Day after surgery

    The length of stay after surgery will be assessed

Sponsors and collaborators

Lead sponsor

San Salvatore Hospital of L'Aquila

Other

Registry information

Official study title

The Analgesic Effect of Qudratus Lomborum Block II Type After Robotic-Assisted Laparoscopic Radical Prostatectomy.

Acronym: QLBII

Important dates

Study start
2019
Primary completion
2020
Study completion
2021
First posted
May 8, 2019
Registry last updated
May 4, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.